Navigation Links
Blue Marble Biomaterials Secures Distribution Agreement with SAFC
Date:1/23/2013

Missoula, Montana, USA (PRWEB) January 23, 2013

Blue Marble Biomaterials, a specialty biochemical manufacturer founded in Seattle, Washington and based in Missoula, Montana, has secured an exclusive distribution contract with Sigma-Aldrich® Corporation’s custom manufacturing and services business unit, SAFC®. As a global manufacturer and distributor of specialty chemicals used in a wide variety of industries including food and beverage flavors, personal care ingredients, scientific research, biotechnology and pharmaceuticals, the agreement gives SAFC’s customers ready access to Blue Marble’s offer of natural and sustainable biochemical alternatives. These products will be sold under the SAFC portfolio and are expected to be available for purchase in April of 2013.

“We are excited to announce this agreement with SAFC. Over the past several months, we worked closely together to develop a comprehensive strategy to offer our all-natural, drop-in replacement biochemicals to its customers. In 2010, twenty percent of all chemicals sold globally were sustainable. By 2025, the United States Department of Agriculture predicts that 45 to 50% of all chemicals sold will be sustainable. This relationship helps to illustrate the trend that is occurring with natural biochemicals and through this agreement with Blue Marble, SAFC has the potential to be the market frontrunner in offering natural biochemicals to its customers,” said Colby Underwood, Co-CEO and Chief Business Officer for Blue Marble Biomaterials.

About Blue Marble Biomaterials: Blue Marble Biomaterials is a wholly owned subsidiary of Blue Marble Energy. Blue Marble Biomaterials manufactures renewable specialty chemicals for the food, fragrance, cosmetics, and personal care industries in a zero-waste, carbon neutral production facility in Missoula, Montana. Their mission is to replace petroleum-based chemicals with fully sustainable, zero carbon specialty chemicals. For more information on Blue Marble go to: http://www.bluemarblebio.com.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company whose biochemical, organic chemical products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma-Aldrich customers include more than 1.3 million scientists and technologists in life science companies, university and government institutions, hospitals and industry. The Company operates in 38 countries and has nearly 9,000 employees whose objective is to provide excellent service worldwide. Sigma-Aldrich is committed to accelerating customer success through innovation and leadership in Life Science and High Technology. For more information about Sigma-Aldrich, please visit its website at http://www.sigma-aldrich.com.

About SAFC: SAFC, the custom manufacturing and services business unit of Sigma-Aldrich Corporation, is recognized as a top 10 global specialty chemicals and biologics supplier. As a trusted manufacturer for the life science and high technology industries, SAFC works closely with customers to resolve development challenges and accelerate the product pipeline utilizing its global "Centers of Excellence" and dedicated manufacturing facilities. Its rich portfolio includes high-purity inorganic materials for high technology applications, critical raw materials and extensive biologics safety testing services for biopharmaceutical manufacturing, and complex, high-potent APIs and key intermediates for pharmaceutical manufacturing. For more information, visit http://www.safcglobal.com.

Contact for Blue Marble Biomaterials:
Colby Underwood – Co-CEO/Chief Business Officer
(206) 779-1494 mobile - colby(dot)underwood(at)bluemarblebio(dot)com

Read the full story at http://www.prweb.com/releases/2013/1/prweb10349707.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Biomaterials China News 1210 - Annual Subscription
2. IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey
3. The Alliance for Regenerative Medicine forms Tissue Engineering and Biomaterials Committee
4. LA Dental Bone Graft Substitute & Other Biomaterials Market Reviewed in New iData Research Report Available at MarketPublishers.com
5. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
6. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
7. Roka Bioscience Secures $47.5 Million in Series D Financing
8. Generex Secures Commitments for $3.6M Capital Raise
9. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
10. Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital
11. Bacterin Secures $25 Million Financing with OrbiMed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... , ... February 21, 2017 , ... ... organizations to build connected digital health applications, announced a partnership with Redox, a ... to seamlessly connect to many clinical systems while keeping data secure in the ...
(Date:2/21/2017)... ... February 21, 2017 , ... Genedata, a leading provider ... announced the establishment of Genedata Limited as a new subsidiary in the United ... in life science informatics. Creating the UK subsidiary reinforces Genedata’s commitment to collaborate ...
(Date:2/21/2017)... ... February 21, 2017 , ... The medical potential of stem cells is both ... of medicine, due to their differentiating characteristics. Stem cells are unique as the have ... be induced to become tissue or organic-specific cells with special functions. , Stem ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... manufacturing facility at its headquarters laboratory in Poway, California. Based upon 12 ... of both in-house personnel and consultants, VetStem constructed and validated a state-of-the-art GMP ...
Breaking Biology Technology:
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
(Date:2/7/2017)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the latest release ... flexible and award winning eClinical solution, is now available ... is a proven Software-as-a-Service (SaaS) clinical research technology platform ... also delivers an entire suite of eClinical tools to ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute ... Larry Schlesinger as the Institute,s new President ... Biomed effective May 31, 2017. He is currently the Chair ... of the Center for Microbial Interface Biology at Ohio State ... as the new President and CEO of Texas Biomed," said ...
Breaking Biology News(10 mins):